Accelerate Diagnostics Cash Flow - Annual (NASDAQ:AXDX)

Add to My Stocks
$28.85 $0.75 (2.67%) AXDX stock closing price May 24, 2017 (Closing)

The Accelerate Diagnostics cash flow statement helps investors understand how well the company is managing its cash flows. While its important to look at the Accelerate Diagnostics debt position, the cash flow statement becomes equally important because public companies use accrual accounting. For example, if a company sells a product which gets counted as Accelerate Diagnostics revenue but does not convert to cash because it does not receive payment in the same quarter, it affects the cash position for that period. Accelerate Diagnostics cash flow analysis is possible because this statement breaks down how balance sheet accounts and income statement items affect cash and cash equivalents.  Accelerate Diagnostics had cash and cash equivalents of $120.58M at the beginning of the year and $19.24M at year end for 2016.   Accelerate Diagnostics has a negative cash and cash equivalents change of $-101.34M. View details of Accelerate Diagnostics cash flows for latest & last ten financial years.

show more
View Previous Years
View Next Years
Fiscal year is Jan - Dec. 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007
Accelerate Diagnostics Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow2.72M1.98M1.15M0.43M-0.06M0.06M0.06M0.06M0.07M
Net Increase (Decrease) in Assets Liabilities1.54M-1.36M1.25M--0.01M-0.16M0.04M-0.06M0.16M
Cash From (used in) Discontinued Operations----------
Other Adjustments Net8.7M8.38M9.62M3.83M-0.27M-0.01M-0.14M-0.01M
Accelerate Diagnostics Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment-2.4M-3.65M-1.93M-1.15M------
Acquisition Disposition of Subsidiaires----------
Increase (Decrease) in Investments-47.15M0.98M-1.43M-12.01M-----0.01M-
Other Cash Inflow (Outflow) from Investment Activities------0.08M-0.01M-0.08M-0.07M-0.11M
Accelerate Diagnostics Net Cash from (used by) Invesment Activities
Issuance (Purchase) of Equity Shares1.72M104.97M45.79M40.88M------
Issuance (Repayment) of Debt Securities-0.01M-0.14M-0.1M-------
Increase (Decrease) in Bank & Other Borrowings----------
Payment of Dividends & Other Cash Distributions----------
Other Cash from (used by) Financing Activities
Accelerate Diagnostics Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash-0.12M---------
Accelerate Diagnostics Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year120.58M53.56M30.02M12.06M-0.77M0.28M0.86M1.23M1.39M
Cash & Equivalents at Year End19.24M120.58M53.56M30.02M-0.58M0.22M0.47M1.08M1.02M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years
Get Cash flow for another ticker

The statement of cash flows comprises of cash flow from financing, cash flow from operations and cash flow from investing activities. All the three can have an impact on the stock price. The Accelerate Diagnostics stock price history and Accelerate Diagnostics stock comparison chart inevitably reflect its cash flow situation.
  • Net Change in Cash and Cash Equivalents: Accelerate Diagnostics cash reduced YoY to $-66.37M, meaning the company is unable to meet its expenditure and grow cash which will also eventually reflect in the Accelerate Diagnostics stock price movement.
  • Cash Flow from operating activities: This is the cash that the company receives from ongoing operations. Accelerate Diagnostics lost $18.28M cash from operations. It is important to check this to see where the company is getting its money from.
  • Cash from investing stood at a negative value of $-49.56M for AXDX stock. A company with surplus cash usually thinks of re-investing it in the form of buying fixed assests, or purchasing plant/ machinery which will help grow the business further. By looking at cash flow from investment activities one can check where the company is putting its cash.
  • Cash Flow from financing activities: The cash inflow/outflow from financing activities was $1.76M for Accelerate Diagnostics. The money accounted for under this head comes from external sources which includes lenders, investors and shareholders. Positive cash flow is generated when the company gets cash because of issuance of stocks or bonds. Similarly negative cash flow is generated when shares are repurchased, dividend payments are made, and loans or interest on loans are paid back.

Key Financial Ratios For Accelerate Diagnostics Cash Flow

FCF margin